NUCALA Autoinjector: a patient perspective

What could the Autoinjector mean to your patients? Watch now and find out.

  • transcript

    TEXT ONSCREEN:
    What could the AUTOINJECTOR MEAN TO YOUR PATIENTS?
    Intended for US HCP audience only.

    NARRATOR:
    What could the Autoinjector mean to your patients?

    TEXT ONSCREEN:
    Nucala (mepolizumab) Injection 100 mg/mL

    IMPORTANT PRODUCT INFORMATION
    NUCALA is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype. NUCALA is not indicated for the relief of acute bronchospasm or status asthmaticus.

    Please review additional Important Product Information for NUCALA near the end of this video.

    Please see full Prescribing Information for NUCALA at NUCALAHCP.com.

    ANNOUNCER:
    NUCALA is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype. NUCALA is not indicated for the relief of acute bronchospasm or status asthmaticus.
    Please review additional Important Product Information for NUCALA near the end of this video.

    TEXT ONSCREEN:
    What does the Autoinjector* mean to me?

    *For patients 12 years and older

    NARRATOR:
    What does the Autoinjector mean to me? A lot, actually.

    TEXT ONSCREEN:
    My doctor recommended at-home administration

    NARRATOR:
    Ever since my doctor recommended at-home administration of NUCALA for my severe eosinophilic asthma, there have been some nice changes.

    TEXT ONSCREEN:
    Instead of driving to the doctor's for my injection

    NARRATOR:
    Instead of spending time driving to my doctor's for my injection,

    TEXT ONSCREEN:
    I'm on the driving range

    NARRATOR:
    I'm spending time on the driving range.

    TEXT ONSCREEN:
    Instead of sitting in the waiting room

    NARRATOR:
    Instead of sitting in the waiting room,

    TEXT ONSCREEN:
    I'm sitting in my living room

    NARRATOR:

    I'm sitting in my living room.

    TEXT ONSCREEN:
    Instead of planning an appointment for my injection

    NARRATOR:
    And instead of planning an appointment for my injection,

    TEXT ONSCREEN:
    I'm planning a weekend downtown

    NARRATOR:
    I'm planning a weekend downtown.

    TEXT ONSCREEN:
    Once my doctor showed me how to use it
    Please see the full Instructions for Use at NUCALA.com/how-to-use

    NARRATOR:
    I wasn't sure about it at first, but once my doctor showed me how to use it,

    TEXT ONSCREEN:
    I was all for it
    Please see the full Instructions for Use at NUCALA.com/how-to-use

    NARRATOR:
    I was all for it.

    TEXT ONSCREEN:
    Nucala (mepolizumab) Injection 100 mg/mL
    IMPORTANT PRODUCT INFORMATION (cont’d)
    NUCALA is for the add-on maintenance treatment for patients 6+ with severe eosinophilic asthma (SEA). Not for acute bronchospasm or status asthmaticus.
    May cause hypersensitivity reactions (eg, anaphylaxis, angioedema, bronchospasm, hypotension, urticaria, rash).
    Herpes zoster has occurred.
    Do not stop systemic/inhaled corticosteroids abruptly.
    Treat pre-existing helminth infections before starting NUCALA.
    Most common adverse reactions: headache, injection site reactions, back pain, fatigue.
    Please see full Prescribing Information for NUCALA at NUCALAHCP.com.

    ANNOUNCER:

    NUCALA is for the add-on maintenance treatment for patients 6+ with severe eosinophilic asthma (SEA). Not for acute bronchospasm or status asthmaticus.
    May cause hypersensitivity reactions (eg, anaphylaxis, angioedema, bronchospasm, hypotension, urticaria, and rash).
    Herpes zoster has occurred.
    Do not stop systemic/inhaled corticosteroids abruptly.
    Treat pre-existing helminth infections before starting NUCALA.
    Most common adverse reactions: headache, injection site reactions, back pain, fatigue.

    TEXT ONSCREEN:

    Nucala (mepolizumab) Injection 100 mg/mL

    IMPORTANT PRODUCT INFORMATION (cont’d)

    To report SUSPECTED ADVERSE REACTIONS, contact GSK at 1-888-825-5249 or FDA at 1-800-FDA-1088
    or www.fda.gov/medwatch.
    NUCALA (mepolizumab) injection is available as a 100 mg/mL vial, Autoinjector, and prefilled syringe.
    Please see full Prescribing Information for NUCALA at NUCALAHCP.com.

    ANNOUNCER:
    Please see full Prescribing Information at NucalaHCP.com

    TEXT ONSCREEN:

    Nucala (mepolizumab) Injection 100 mg/mL
    Learn more at NucalaTreatmentOptions.com
    Trademarks are owned by or licensed to the GSK group of companies.

    GSK
    ©2024 GSK or licensor.
    PMUS-MPLADVT240003 May 2024
    Produced in USA.

    ANNOUNCER:
    Learn more at NucalaTreatmentOptions.com